Skip to content

Latest Post

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss Manipur Liquor Tragedy: Toll Hits 15 as 300+ Treated for Suspected Methanol Poisoning
  • Sun. Nov 22nd, 2026
MedGadget.in logo – medical technology news and healthcare technology insights

  • Home
  • About Us
  • Author
  • Contact Us
Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb

The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn of NAION, a rare cause of sudden vision loss. Here…

Clinical Trials

India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial

November 21, 2026 Simone Lamb

A CDSCO expert panel recommended a Phase I trial of Indian Immunologicals' live attenuated Zika vaccine, developed with Griffith University and funded by ICMR.

Clinical Trials

Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients

November 21, 2026 Simone Lamb

PMV Pharmaceuticals' rezatapopt produced a 48% response rate in platinum-resistant ovarian cancer with TP53 Y220C in the pivotal PYNNACLE trial, with an FDA filing planned…

Clinical Trials

GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss

November 21, 2026 Simone Lamb

Mayo Clinic data from ObesityWeek 2026 show GLP-1 users with weakened hearts saw greater one-year gains in heart structure and function than matched non-users, with…

Healthcare Services

Manipur Liquor Tragedy: Toll Hits 15 as 300+ Treated for Suspected Methanol Poisoning

November 21, 2026 Simone Lamb

Up to 15 people have died and more than 300 have sought care in Imphal after drinking spurious liquor in Manipur's Chandel district. What we…

Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb

The FDA now requires all 12 GLP-1 drugs, including Ozempic, Wegovy and Mounjaro, to warn…

Healthcare IT Medical Device

AI in Neurosurgery Market: Size, Trends, Key Players and Regional Outlook

October 4, 2026 Simone Lamb

AI in neurosurgery market to grow from USD 850 million in 2025 to USD 11.3 billion by 2035 (29.5% CAGR). Growth drivers, key players and regional outlook.

Healthcare IT Medical Device

AI-assisted Surgery Market: Trends, Leaders and Regional Outlook

October 4, 2026 Simone Lamb

AI-assisted surgery market to reach USD 39.31 billion by 2035 at 26.8% CAGR. Key growth trends, leading companies and how regions compare, led by North America.

Pharmaceutical

TIL Healthcare Sri City Boiler Explosion: What We Know

October 3, 2026 Simone Lamb

A boiler explosion at the TIL Healthcare plant in Sri City, Andhra Pradesh on 3 October left several workers dead and injured; cause under investigation.

Pharmaceutical

Maharashtra FDA Cancels Cipla Pune Warehouse Drug Licences

October 3, 2026 Simone Lamb

Maharashtra FDA cancelled the drug sale and distribution licences of Cipla Pune Wadki warehouse on 1 October over alleged lapses. Cipla calls it disappointing.

Pharmaceutical

FDA Extends Review of Novo Denecimig Over Facility Issues

October 3, 2026 Simone Lamb

FDA extended its denecimig review as manufacturing-site remediation continues. No efficacy or safety issues were cited; Novo now expects a US launch in H1 2027.

Healthcare Services

Pennsylvania Measles Outbreak Nears 1,000 With 977 Cases

October 3, 2026 Simone Lamb

Pennsylvania measles outbreak reached 977 confirmed cases in 39 counties as of 2 October, with 195 hospitalised and five deaths; MMR doses have surged.

Pharmaceutical

Bayer Ohio Plant: $2.2 Billion Pharma Site in New Albany

October 3, 2026 Simone Lamb

Bayer will invest $2.2 billion in a New Albany, Ohio pharmaceutical campus with about 600 permanent jobs; the first module is due by 2031.

Pharmaceutical

Datroway Ivonescimab Phase III Planned in First-Line TNBC

October 2, 2026 Simone Lamb

Datroway ivonescimab trials will start with a Phase III in first-line triple-negative breast cancer in a new AstraZeneca, Daiichi Sankyo and Summit pact.

Pharmaceutical

Novartis Abogen Deal: $7.8 Billion mRNA Autoimmune License

October 2, 2026 Simone Lamb

Novartis Abogen deal: Abogen gets $575 million upfront and up to $7.2 billion in milestones for ABO2203, an mRNA T-cell engager for autoimmune disease.

Pharmaceutical

PRIP Scheme: India Backs 41 Pharma, MedTech R&D Projects

October 2, 2026 Simone Lamb

PRIP scheme: India approved about ₹1,600 crore for 41 pharma and MedTech R&D projects, expected to draw ₹3,020 crore more in private investment.

Posts pagination

1 … 30 31 32 … 36

You missed

Pharmaceutical

Ozempic NAION Warning: FDA Adds Rare Eye Risk to Every GLP-1 Drug Label

November 21, 2026 Simone Lamb
Clinical Trials

India’s First Zika Vaccine Wins CDSCO Panel Nod for Phase I Trial

November 21, 2026 Simone Lamb
Clinical Trials

Rezatapopt Ovarian Cancer Data: p53 Pill Shrinks Tumours in 48% of Platinum-Resistant Patients

November 21, 2026 Simone Lamb
Clinical Trials

GLP-1 Heart Failure Study: Semaglutide and Tirzepatide Remodel Weak Hearts Beyond Weight Loss

November 21, 2026 Simone Lamb
MedGadget.in logo – medical technology news and healthcare technology insights

Proudly powered by WordPress | Theme: NewsTwenty by Themeansar.

  • Home
  • About Us
  • Author
  • Contact Us